$AGTX
Agentix Corp.

2022 Q4 Form 10-Q Financial Statement

#000147793222008435 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $1.240K
YoY Change -100.0%
Cost Of Revenue $0.00 $0.00 $560.00
YoY Change -100.0%
Gross Profit $0.00 $0.00 $680.00
YoY Change -100.0%
Gross Profit Margin 54.84%
Selling, General & Admin $161.6K $139.8K $130.2K
YoY Change 30.54% 7.38% 501.06%
% of Gross Profit 19145.59%
Research & Development $192.0K $284.5K $113.9K
YoY Change 347.11% 149.79% 21.05%
% of Gross Profit 16751.47%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $353.6K $424.3K $244.1K
YoY Change 112.08% 73.83% -125.38%
Operating Profit -$353.6K -$424.3K -$243.4K
YoY Change 112.08% 74.31%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0%
Pretax Income -$353.6K -$424.3K -$243.4K
YoY Change 112.08% 74.31% -125.71%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$353.6K -$424.3K -$243.4K
YoY Change 112.08% 74.31% -125.71%
Net Earnings / Revenue -19631.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$10.87K -$6.980K
COMMON SHARES
Basic Shares Outstanding 38.92M shares 38.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $680.00 $2.700K $1.770K
YoY Change -45.16% 52.54% -99.27%
Cash & Equivalents $679.00 $2.702K $1.768K
Short-Term Investments
Other Short-Term Assets $110.8K $5.830K $0.00
YoY Change -100.0%
Inventory $49.44K
Prepaid Expenses $5.833K $0.00
Receivables
Other Receivables
Total Short-Term Assets $111.5K $8.535K $51.21K
YoY Change 119.98% -83.33% -82.51%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $111.5K $8.535K $51.21K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $111.5K $8.535K $51.21K
YoY Change 119.98% -83.33% -82.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $625.2K $405.6K $121.2K
YoY Change 417.7% 234.51% 75.23%
Accrued Expenses $100.00 $100.00 $100.00
YoY Change 0.0% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.975M $1.625M $606.9K
YoY Change 155.4% 167.66% 775.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.975M $1.625M $606.9K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.975M $1.625M $606.9K
YoY Change 155.4% 167.66% 775.94%
SHAREHOLDERS EQUITY
Retained Earnings -$4.938M -$4.585M -$1.704M
YoY Change 163.93% 169.0%
Common Stock $39.12K $39.12K $34.88K
YoY Change 11.52% 12.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.863M -$1.616M -$555.7K
YoY Change
Total Liabilities & Shareholders Equity $111.5K $8.535K $51.21K
YoY Change 119.98% -83.33% -82.51%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$353.6K -$424.3K -$243.4K
YoY Change 112.08% 74.31% -125.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $200.00 -$47.48K -$6.040K
YoY Change -137.66% 686.09% -98.36%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 50.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 200.0 -47.48K -6.040K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 50.00K 0.000
Net Change In Cash 200.0 2.520K -6.040K
YoY Change -137.66% -141.72% -102.49%
FREE CASH FLOW
Cash From Operating Activities $200.00 -$47.48K -$6.040K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5833 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2929406 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2879606 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4584505 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3995521 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1615982 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1076998 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8535 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15978 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
100 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1624517 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1624517 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
39117 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39116951 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001603345
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38916951 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39116951 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55383
dei Entity Registrant Name
EntityRegistrantName
AGENTIX CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2876282
dei Entity Address Address Line1
EntityAddressAddressLine1
32932 Pacific Coast Highway
dei Entity Address Address Line2
EntityAddressAddressLine2
#14-254
dei Entity Address City Or Town
EntityAddressCityOrTown
Dana Point
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92629
dei City Area Code
CityAreaCode
321
dei Local Phone Number
LocalPhoneNumber
299-2041
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38916931 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38916951 shares
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
1240 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
1240 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
561 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
561 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
679 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
679 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
114130 usd
us-gaap Professional Fees
ProfessionalFees
156852 usd
us-gaap Professional Fees
ProfessionalFees
202768 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91487 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
335644 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
153987 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15309 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
96488 usd
us-gaap Operating Expenses
OperatingExpenses
387884 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-220247 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-588984 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-387205 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-424330 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-220247 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
361569 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47443 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
531541 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-424330 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-220247 usd
CY2022Q3 agtx Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.01
CY2021Q3 agtx Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.01
agtx Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.02
agtx Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.01
CY2022Q3 agtx Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
39030284 shares
CY2021Q3 agtx Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
34874605 shares
agtx Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
38944896 shares
agtx Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
34874605 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1076998 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-164654 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1241652 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-424330 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-220366 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-166958 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-387324 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-220247 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-607571 usd
us-gaap Profit Loss
ProfitLoss
588984 usd
us-gaap Profit Loss
ProfitLoss
387205 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
10000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
49439 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-50000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25075 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2557 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25075 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25349 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2702 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
274 usd
agtx General And Administrative Expenses Subscription
GeneralAndAdministrativeExpensesSubscription
10000 usd
CY2022Q3 agtx General And Administrative Expenses To Be Expensed
GeneralAndAdministrativeExpensesToBeExpensed
5833 usd
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
22346 shares
CY2022 agtx Software Subscription
SoftwareSubscription
20000 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39116951 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38916951 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
200000 shares
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.25
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 usd

Files In Submission

Name View Source Status
0001477932-22-008435-index-headers.html Edgar Link pending
0001477932-22-008435-index.html Edgar Link pending
0001477932-22-008435.txt Edgar Link pending
0001477932-22-008435-xbrl.zip Edgar Link pending
agtx-20220930.xsd Edgar Link pending
agtx_10q.htm Edgar Link pending
agtx_ex311.htm Edgar Link pending
agtx_ex312.htm Edgar Link pending
agtx_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
agtx-20220930_cal.xml Edgar Link unprocessable
agtx-20220930_def.xml Edgar Link unprocessable
agtx-20220930_pre.xml Edgar Link unprocessable
agtx-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
agtx_10q_htm.xml Edgar Link completed